Detalhe da pesquisa
1.
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
N Engl J Med
; 381(12): 1124-1135, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150573
2.
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.
Int J Cancer
; 145(1): 295-305, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613964
3.
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
Lancet Oncol
; 17(11): 1509-1520, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686945
4.
Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
Pharmazie
; 69(2): 132-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24640603
5.
Anticancer effects of celecoxib through inhibiton of STAT3 phosphorylation and AKT phosphorylation in nasopharyngeal carcinoma cell lines.
Pharmazie
; 69(5): 358-61, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855827
6.
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.
Lancet Oncol
; 13(2): 163-71, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22154591
7.
Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
Acta Pharmacol Sin
; 33(5): 682-90, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22504904
8.
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 40(22): 2420-2425, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35709465
9.
Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
Medicine (Baltimore)
; 99(36): e21785, 2020 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32899005
10.
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial.
Eur J Cancer
; 75: 150-158, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28235726
11.
Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.
Int J Oncol
; 44(5): 1551-60, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24603891
12.
Single-arm, multi-centre phase II study of lobaplatin combined with docetaxel for recurrent and metastatic nasopharyngeal carcinoma patients.
Oral Oncol
; 50(8): 717-20, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24844985
13.
Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner.
Chin Med J (Engl)
; 126(12): 2242-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23786932
14.
Decreased expression of the carboxyl terminus of heat shock cognate 70 interacting protein in human gastric cancer and its clinical significance.
Oncol Rep
; 28(4): 1392-8, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895543
15.
Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chin Med J (Engl)
; 125(13): 2322-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22882856